Niche technologies will differentiate CMOs looking for a slice of the steady oral dosage manufacturing industry, according to an industry report from ISR.
Samsung Biologics has invested $740m to build a third facility in Korea, adding a further 180,000L of mammalian cell culture capacity.
Clariant will build a CHF10m ($9.7m) moisture control device plant in Cuddalore, Tamil Nadu to cater for the branded and generic drugmakers operating in India.
Quintiles and Covance say they can offer the personal touch to small pharma and biotech, but Outsourcing-Pharma asks whether it is better for sponsors to stick to similar-sized CROs?
Private-equity backed contractor Synerlab has bought Spain’s Alcala Farma in a bid to expand its European reach and revenue base.
Big Pharma bureaucracy makes trials less efficient but listening to CRO partners can help reverse this, say experts from Pfizer, Bayer and Grunenthal.